Log In
Print
BCIQ
Print
Print this Print this
 

CG0070

  Manage Alerts
Collapse Summary General Information
Company Cold Genesys Inc.
DescriptionModified adenovirus expressing GM-CSF
Molecular Target Granulocyte macrophage colony-stimulating factor (GM-CSF) (CSF2)
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationBladder cancer
Indication DetailsTreat non-invasive bladder cancer; Treat recurrent bladder cancer
Regulatory Designation

U.S. - Special Protocol Assessment (Treat non-invasive bladder cancer)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today